Dynamic Capital Management’s United Therapeutics UTHR Stock Holding History

Dynamic Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-15,440	Closed	-$2.28M	–	244
2017 Q4	$2.28M	Buy	+15,440	New	+$1.96M	0.79%	33
2016 Q4	–	Sell	-4,302	Closed	-$508K	–	465
2016 Q3	$508K	Buy	+4,302	New	+$517K	0.07%	291
2016 Q2	–	Sell	-8,329	Closed	-$928K	–	491
2016 Q1	$928K	Buy	+8,329	New	+$1.05M	0.35%	66
2015 Q4	–	Sell	-14,069	Closed	-$1.85M	–	459
2015 Q3	$1.85M	Buy	14,069 +12,133	+627%	+$1.95M	0.51%	55
2015 Q2	$337K	Sell	1,936 -45,399	-96%	-$8.17M	0.09%	205
2015 Q1	$8.16M	Buy	+47,335	New	+$7.22M	2.93%	4
2014 Q3	–	Sell	-4,263	Closed	-$377K	–	458
2014 Q2	$377K	Buy	4,263 +280	+7%	+$26.9K	0.11%	294
2014 Q1	$375K	Buy	+3,983	New	+$407K	0.12%	291
2013 Q3	–	Sell	-3,600	Closed	-$237K	–	514
2013 Q2	$237K	Buy	+3,600	New	+$232K	0.06%	310

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

Dynamic Capital Management's UTHR Position: Q1 2018 in Review

Dynamic Capital Management sold out of United Therapeutics (UTHR) in Q1 2018, closing a stake of 15,440 shares — an estimated $2.28M sold.

Dynamic Capital Management first reported a position in UTHR in Q2 2013 and held it in 9 quarters. The position peaked at $8.16M in Q1 2015. 374 funds tracked by Wall St. Rank hold UTHR as of Q1 2018.

Dynamic Capital Management reported no remaining United Therapeutics position as of Q1 2018 after selling out during the quarter.
Dynamic Capital Management sold 15,440 United Therapeutics shares in Q1 2018, an estimated $2.28M.
Dynamic Capital Management first reported a position in United Therapeutics in Q2 2013 and held it in 9 quarters.
Dynamic Capital Management's United Therapeutics position peaked at $8.16M in Q1 2015.
374 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2018.

Based on Dynamic Capital Management's 13F filing for Q1 2018, filed 14 May 2018.